A new structural analogue antagonist of peptido-leukotrienes. The discovery of bay x7195

1993

Abstract Systematic modification of LTD 4 has led to the discovery of BAY x7195 , a potent, selective, orally-active peptido-leukotriene antagonist.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

4

References

16

Citations